AngioDynamics, Inc.

NASDAQ:ANGO

Medical - Instruments & Supplies

Healthcare
$11.32 +1.71%

+$0.20 today

Market cap
$476.06M
Beta
0.36
P/E (TTM)
-15.8
EPS (TTM)
-$0.75
52W Low $8.36High $13.99

Volume 0.32M

Average 0.40M

ANGO Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

AngioDynamics, Inc.NASDAQ: ANGO

Gross Margin · Q3 FY2026 · quarter ended Feb 2026

Gross margin narrows to 52.9%

Gross margin was 52.9% in Q3 FY2026, down 1.1 pp from a year earlier. On a trailing-twelve-month basis it was 53.5%, down 0.9 pp year over year. Over 3 fiscal years it widened by 1.5 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterFeb 2026
52.9%-0.2 pp QoQ
Last fiscal yearMay 2025
53.9%+3.0 pp YoY
LTMFeb 2026
53.5%-0.9 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-1.1 pp——
1 year+3.0 pp——
3 years+1.5 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
53.9%
Year-over-year change
+3.0pp

Gross Margin vs competitors

How ANGO compares with its peers on the latest reported figures

  • ANGO's LTM Feb 2026 gross margin of 53.5% is the 6th highest of the 9 companies compared; the peer median is 53.7%.
  • Its year-over-year change of -0.9 pp is the 7th highest of 9, against a peer median of +1.2 pp.
  • Over three fiscal years its change of +1.5 pp compares with a peer median of +3.8 pp.
ANGO Competitors Peer median
Gross Margin for ANGO and competitors
Company Period LTM level YoY 3-year change
LMATLeMaitre Vascular, Inc.LTM Mar 202672.4% +3.6 pp+6.6 pp
BSXBoston Scientific CorporationLTM Jun 202671.2% +7.9 pp+8.2 pp
PENPenumbra, Inc.LTM Jun 202667.8% +1.4 pp+4.0 pp
TFXTeleflex IncorporatedLTM Jun 202653.8% -1.8 pp+1.4 pp
CNMDCONMED CorporationLTM Mar 202653.6% -1.9 pp-1.9 pp
ANGOAngioDynamics, Inc.LTM Feb 202653.5% -0.9 pp+1.5 pp
IARTIntegra LifeSciences Holdings CorporationLTM Mar 202653.2% -0.3 pp-10.6 pp
MMSIMerit Medical Systems, Inc.LTM Sep 202649.4% +0.9 pp+3.6 pp
BDXBecton, Dickinson and CompanyLTM Sep 202647.0% +1.6 pp+5.2 pp
Peer median (excluding ANGO) 53.7%+1.2 pp+3.8 pp

Competitors are the stored peer set for ANGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
May 2021
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
Revenue291.01M316.22M338.75M303.91M292.5M
Cost of Revenue134.22M150.49M164.51M149.22M134.79M
Gross Profit156.79M165.73M174.25M154.7M157.71M
Gross Margin53.9%52.4%51.4%50.9%53.9%
Research & Development36.39M30.74M29.88M31.51M26.22M
Selling, General & Admin117.22M133.75M144.25M143.98M145.23M
Operating Expenses192.07M194.2M225.43M347.13M197.66M
Depreciation & Amortization25.92M29.35M30.87M27.71M25.8M
EBITDA(9.28M)11.13M12.19M(6.13M)1.74M
EBITDA Margin-3.2%3.5%3.6%-2.0%0.6%
Operating Income(35.28M)(28.47M)(51.18M)(192.44M)(39.95M)
Operating Margin-12.1%-9.0%-15.1%-63.3%-13.7%
Interest Income0001.61M978K
Interest Expense861K688K2.7M00
Other Income / Expenses(769K)(1.48M)(3.26M)797K5.92M
Income Before Tax(36.05M)(29.95M)(54.44M)(191.64M)(34.03M)
Pre-Tax Margin-12.4%-9.5%-16.1%-63.1%-11.6%
Income Tax Expense(4.5M)(3.4M)(2M)(7.29M)(39K)
Net Income(31.55M)(26.55M)(52.44M)(184.35M)(33.99M)
Net Margin-10.8%-8.4%-15.5%-60.7%-11.6%
EPS (Basic)(0.82)(0.68)(1.33)(4.59)(0.83)
EPS (Diluted)(0.82)(0.68)(1.33)(4.59)(0.83)
Weighted Avg Shares38.34M39.01M39.48M40.18M40.98M
Weighted Avg Shares (Diluted)38.34M39.01M39.48M40.18M40.98M

AngioDynamics, Inc.

NASDAQ:ANGO

Intrinsic Alpha fair value

Locked

Current Price

$11.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.